Evidence map›Paper›PMID 35396264›Full record

ArticleBMJ global health2022

Estimating the contribution of transmission in primary healthcare clinics to community-wide TB disease incidence, and the impact of infection prevention and control interventions, in KwaZulu-Natal, South Africa.

Nicky McCreesh, Aaron S Karat, Indira Govender, Kathy Baisley, Karin Diaconu, Tom A Yates, Rein Mgj Houben, Karina Kielmann, Alison D Grant, Richard White

Open access · goldAbstract read
In one paragraph

Article in BMJ global health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Nicky McCreeshTB Centre, London School of Hygiene and Tropical Medicine, London, UK nicky.mccreesh@lshtm.ac.uk.ORCID 0000-0003-1409-8531
Aaron S KaratTB Centre, London School of Hygiene and Tropical Medicine, London, UK.ORCID 0000-0001-9643-664X
Indira GovenderTB Centre, London School of Hygiene and Tropical Medicine, London, UK.ORCID 0000-0003-0598-7388
Kathy BaisleyTB Centre, London School of Hygiene and Tropical Medicine, London, UK.ORCID 0000-0003-1849-6625
Karin DiaconuThe Institute for Global Health and Development, Queen Margaret University, Musselburgh, UK.ORCID 0000-0002-5810-9725
Tom A YatesDepartment of Infectious Disease, Faculty of Medicine, Imperial College London, London, UK.ORCID 0000-0002-6081-1767
Rein Mgj HoubenTB Centre, London School of Hygiene and Tropical Medicine, London, UK.ORCID 0000-0003-4132-7467
Karina KielmannThe Institute for Global Health and Development, Queen Margaret University, Musselburgh, UK.ORCID 0000-0001-5519-1658
Alison D GrantTB Centre, London School of Hygiene and Tropical Medicine, London, UK.ORCID 0000-0002-2437-5195
Richard WhiteTB Centre, London School of Hygiene and Tropical Medicine, London, UK.ORCID 0000-0003-4410-6635
London School of Hygiene & Tropical Medicine · GBQueen Margaret University · GBImperial College London · GBUniversity of the Witwatersrand · ZA

Funding

Defining drivers of TB transmission in the era of universal ART, and implications for finding the walking wellR01AI147321 · NIAID · LONDON SCH/HYGIENE & TROPICAL MEDICINE · PI GRANT, ALISON · 2019 to 2024
$2.3M
Gates Foundation INV-001754Medical Research Council MR/R010161/1NIAID NIH HHS R01 AI147321Wellcome Trust
6 · The paper itself

Abstract

backgroundThere is a high risk of

methodsWe developed an individual-based model of

resultsWe estimate that 7.6% (plausible range 3.9%-13.9%) of non-multidrug resistant and multidrug resistant TB in adults resulted directly from transmission in PHC clinics in the community in 2019. The proportion is higher in HIV-positive people, at 9.3% (4.8%-16.8%), compared with 5.3% (2.7%-10.1%) in HIV-negative people. We estimate that IPC interventions could reduce incident TB cases in the community in 2021-2030 by 3.4%-8.0%, and deaths by 3.0%-7.2%.

conclusionsA non-trivial proportion of TB results from transmission in clinics in the study community, particularly in HIV-positive people. Implementing IPC interventions could lead to moderate reductions in disease burden. We recommend that IPC measures in clinics should be implemented for their benefits to staff and patients, but also for their likely effects on TB incidence and mortality in the surrounding community.

Indexed as

HIV InfectionsTuberculosisAdultHumansIncidencePrimary Health CareSouth AfricaepidemiologyHIVmathematical modellingpublic healthtuberculosis

Identifiers

PMID35396264
PMCPMC8995945
OpenAlexW4226189256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.